New synthetic bone graft tested against donor tissue in spine surgery
NCT ID NCT05037968
First seen Jun 27, 2026 · Last updated Jul 08, 2026 · Updated 2 times
Summary
This study compares two bone graft materials used in spine fusion surgery for patients with degenerative disc disease and back or leg pain. One is a synthetic material called MagnetOs Flex Matrix, and the other is a donor-based graft called Trinity Elite. About 100 adults will be randomly assigned to receive one of the two grafts during surgery, and doctors will check how well the bones fuse using CT scans and X-rays over 12 months.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- MagnetOs Flex Matrix (synthetic bone graft) and Trinity Elite (donor bone graft)
- What this could lead to
- If successful, this study could show that a synthetic bone graft works as well as a donor-based graft for spine fusion, offering a reliable alternative.
- What could go wrong
- This is a small, early-phase study with only 100 participants. Results may not apply to all patients, and there is always a risk that the synthetic graft may not fuse bones as effectively.
Why investors are watching
Kuros Biosciences AG is a micro-cap company, and this trial is its bone graft product, MagnetOs Flex Matrix, tested against a rival product in spinal fusion surgery. The result matters because a positive outcome could validate MagnetOs as a viable alternative, which is consequential for a company of this size where one product's performance can drive its value.
If it works: A positive result could strengthen the case for MagnetOs Flex Matrix in the spinal fusion market, potentially supporting broader adoption and sales. It may also give the company a competitive edge in a field where surgeons choose between graft options.
If it fails: A negative or inconclusive result could hurt confidence in MagnetOs and slow its commercial uptake. Trials often fail or show no difference, and for a small company, a setback here could weigh on its prospects.
AI-written from the trial record. Speculative, and not investment advice.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 100 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Jun 2024
- Expected to finish
-
Dec 2026
An estimate. End dates often move.
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patient is able to read/be read, understand, and provide written informed consent and has signed the Investigational Review Board (IRB) approved informed consent. * Male or female patient ≥ 18 years old. * Patients with leg pain, and/or back pain requiring up to four-level instrumented posterolateral lumbar/thoraco-lumbar fusion (T11 - S1) * Failed conservative treatment (physical therapy, bed rest, medications, spinal injections, manipulations, or transcutaneous electrical nerve stimulation) for a minimum period of 3 months prior to study enrollment. Exclusion Criteria: * Requires \> four-level fusion or expected to need secondary intervention within one year following surgery. * Had prior PLF fusion or attempted PLF fusion at the involved levels * Had previous decompression at the involved levels. * Women who are or intend to become pregnant within the next 12 months * To treat conditions in which general bone grafting is not advisable. * In conditions where the surgical site may be subjected to excessive impact or stresses, including those beyond the load strength of fixation hardware (e.g., defect site stabilization is not possible). * In case of significant vascular impairment proximal to the graft site. * In case of severe metabolic or systemic bone disorders (e.g., osteogenesis imperfecta or Paget's Disease) that affect bone or wound healing. * In case of acute and chronic infections in the operated area (soft tissue infections; inflammation, bacterial bone diseases; osteomyelitis). * When intraoperative soft tissue coverage is not planned or possible. * Receiving treatment with medication interfering with calcium metabolism. * Had leg pain, and/or back pain related to a benign or malignant tumor. * Had history or presence of active malignancy. * Has known substance abuse, psychiatric disorder, or condition which, in the opinion of the investigator, may influence the healing or ability to comply with protocol requirements. * Is involved in active litigation relating to his/her spinal condition. * Has participated in an investigational study within 30 days prior to surgery for study devices.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Degenerative disc disease are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
8 sites. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Hartford Hospital
RECRUITINGHartford, Connecticut, 06106, United States
-
Huntsman Spinal Clinic
RECRUITINGSalt Lake City, Utah, 84124, United States
-
Inova Healthcare
RECRUITINGFairfax, Virginia, 22031, United States
-
MedStar Health Research Institute
RECRUITINGColumbia, Maryland, 21044, United States
-
Michigan Orthopedic Surgeons
RECRUITINGBloomfield Hills, Michigan, 48033, United States
-
Pinehurst Surgical Clinic
RECRUITINGPinehurst, North Carolina, 28374, United States
-
Rush University Medical Center
RECRUITINGChicago, Illinois, 60612, United States
-
The Ohio State University
RECRUITINGColumbus, Ohio, 43210, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A Non-Opioid pain drug takes aim at Surgery's opioid problem
- Can a dissolvable bone wax curb bleeding during spine fusion?
- A conversation before spine surgery could change how patients recover
- Can a new bone graft match the gold standard for spinal fusion?
- Can a common mineral keep spine surgery safer?
- Can a nanotube surface help spinal bones fuse faster?